The ERA strain of rabies vaccine.
An antigenic extinction trial in cats showed that the ERA rabies vaccine had superior antigenic properties over Flury H.E.P. C.E.O. and killed tissue culture rabies vaccine. Dogs and cats on a duration of immunity study of ERA rabies vaccine were challenged with fox salivary gland "street" rabies virus. The results of this challenge show a duration of immunity of five years in dogs and four years in cats. Vaccination of dams in late pregnancy with ERA rabies vaccine resulted in transference of maternal antibody to the newborn, in both cattle and dogs. This maternally derived antibody interfered with the successful active immunization of the young calf. Calves free of antibodies for rabies could be successfully vaccinated as early as 17 days of age and were able to withstand a challenge with virulent "street" rabies virus two years later.
D000818:Animals; D002371:Cat Diseases / Q000517:prevention & control*; D002415:Cats; D002417:Cattle; D002418:Cattle Diseases / Q000517:prevention & control*; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D007273:Injections, Intramuscular; D008431:Maternal-Fetal Exchange; D009500:Neutralization Tests; D011247:Pregnancy; D011818:Rabies / Q000517:prevention & control / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage; D013997:Time Factors; D014611:Vaccination / Q000662:veterinary*; D014776:Virus Cultivation
D011819:Rabies Vaccines